Faculty

	Thomas W. Samuelson, MD (Chair) Founding Partner and Attending Surgeon Minnesota Eye Consultants Adjunct Professor University of Minnesota Minneapolis, Minnesota
	Mark Hansen, MD Partner Minnesota Eye Consultants Minneapolis, Minnesota
	Judy E. Kim, MD, FARVO, FASRS Professor, Ophthalmology and Visual Sciences Professor, Graduate School of Biomedical Sciences Director, Teleophthalmology and Research Medical College of Wisconsin Milwaukee, Wisconsin
	Jonathan S. Myers, MD Director, Glaucoma Service Wills Eye Hospital Professor of Ophthalmology Sidney Kimmel Medical College Thomas Jefferson University Philadelphia, Pennsylvania

Disclosure Policy

MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.

Faculty

Mark Hansen, MD, has no relevant commercial relationships to disclose.

Judy E. Kim, MD, is an advisory board member of Adverum, Alimera Sciences, Allergan, Apellis Pharmaceuticals, Bausch & Lomb Incorporated, Clearside Biomedical, Inc, D.O.R.C. Dutch Ophthalmic Research Center (International) B.V., Genentech, Inc, Novartis Pharmaceuticals Corporation, Outlook Therapeutics, Inc, and Regeneron Pharmaceuticals, Inc; and is a contracted researcher for Notal Vision.

Jonathan S. Myers, MD, is a consultant for AbbVie Inc, Aerie Pharmaceuticals, Inc, Ancora Biotech LLC, Avisi Technologies Inc, Elios Therapeutics, Glaukos Corporation, Haag-Streit Group, MicroOptx, and Olleyes Inc; and is a contracted researcher for AbbVie, Aerie Pharmaceuticals, Inc, Equinox, Glaukos Corporation, Guardian, Haag-Streit Group, Nicox, Olleyes Inc, Santen Inc, and Thea Pharmaceuticals Limited.

Thomas W. Samuelson, MD, is a consultant for Aerie Pharmaceuticals, Inc, Alcon, Allergan, Bausch & Lomb Incorporated, Belkin Vision, ELT Sight, Equinox, Glaukos Corporation, Imprimis Pharmaceuticals, Inc, Ivantis Inc, Johnson & Johnson Vision Care, Inc, MicroOptx, New World Medical, Inc, Ocuphire Pharma, Polyactiva Pty Ltd, Ripple Therapeutics, Santen Inc, Sight Sciences, TearClear, Valeant, ViaLase, and Zeiss; and has individual stocks and stock options in Belkin Vision, Equinox, Ivantis Inc, Ocuphire Pharma, Sight Sciences, TearClear, and ViaLase.

Peer Reviewers

This activity was peer reviewed. One peer reviewer has no relevant commercial relationships to disclose. The other reviewer, Gennady Landa, MD, formerly served as an advisory board member of EyePoint Pharmaceuticals within the past 2 years, but that relationship has ended.

Planners, Managers, and Writers

Carrie Allen, PharmD, BCPP, BCPS, MedEdicus Content Manager for this activity, was previously employed by CVS within the past 2 years, but that relationship has ended.

Other MedEdicus planners, managers, and writers have no relevant commercial relationships to disclose.